Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 701–725 of 7,816 matching trials · page 29 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) NCT06721156 MK-1167; Placebo Runs in: Argentina; Canada; Italy; Japan; Netherlands; South Korea... · 72 sites |
PHASE2 other |
TERMINATED | 369 | Merck Sharp & Dohme LLC INDUSTRY |
2026-07-01 |
|
18F-mFBG Cardiac Uptake With Lewy Body Dementia NCT07176286 18F-MFBG Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 20 | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) INDUSTRY |
2026-07-01 |
|
Connecting Today to Combat Social Isolation and Loneliness NCT07182019 Connecting Today Runs in: Canada · 1 site |
NA other |
RECRUITING | 320 | University of Alberta OTHER |
2026-07-01 |
|
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies NCT07240805 Runs in: United States · 2 sites |
NA other |
NOT_YET_RECRUITING | 60 | BioSensics INDUSTRY |
2026-07-01 |
|
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease NCT07328451 DNL628; Placebo Runs in: Netherlands; United Kingdom · 4 sites |
PHASE1 other |
RECRUITING | 68 | Denali Therapeutics Inc. INDUSTRY |
2026-07-01 |
|
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation NCT07677865 GLP-1 Receptor Agonists; DPP-4 Inhibitors Runs in: China · 1 site |
NA GLP-1 |
COMPLETED | 213,891 | West China Hospital OTHER |
2026-07-01 |
|
Salivary Gland Massage and Olfactory Stimulation for Relieving Feeding Difficulty and Triggering Oral Intake Among People With Dementia NCT07678515 SMART program (Salivary gland massage combined with aromatherapy Runs in: Taiwan · 1 site |
NA other |
ENROLLING_BY_INVITATION | 30 | National Cheng Kung University OTHER |
2026-07-01 |
|
Digital Learning Technology for Dementia Care Training in Long-term Care Professionals NCT07679230 Dementia care education program; Routine education Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 150 | Tunghai University OTHER |
2026-07-01 |
|
An Intervention to Reduce Discrepancy in Everyday Preferences NCT03577418 Templated, clinician-facilitated intervention to align everyday liv... Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | Mclean Hospital OTHER |
2026-06-30 |
|
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia NCT04430517 Nicotinamide riboside Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 21 | Mclean Hospital OTHER |
2026-06-30 |
|
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease NCT04838301 Allopregnanolone; Placebo Runs in: United States · 9 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 100 | University of Arizona OTHER |
2026-06-30 |
|
Group Drum-Based Music Therapy Intervention for Parkinson's Disease/Huntington's Disease NCT05157074 Group Drumming Music Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 18 | Johns Hopkins University OTHER |
2026-06-30 |
|
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial NCT05189106 Baricitinib Runs in: United States · 2 sites |
PHASE1|PHASE2 other |
COMPLETED | 17 | Massachusetts General Hospital OTHER |
2026-06-30 |
|
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age NCT05399888 Diranersen; Diranersen-matching placebo Runs in: Australia; Belgium; Canada; Czechia; Denmark; Finland; Fr... · 138 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 416 | Biogen INDUSTRY |
2026-06-30 |
|
Fasting ENHANCE Pilot Study NCT05732935 Time Restricted Eating intervention; Successful Aging Comparison Gr... Runs in: United States · 1 site |
NA other |
COMPLETED | 45 | University of Florida OTHER |
2026-06-30 |
|
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease NCT06206824 Leucettinib-21 Runs in: France · 1 site |
PHASE1 other |
COMPLETED | 152 | Perha Pharmaceuticals INDUSTRY |
2026-06-30 |
|
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) NCT06947941 KarXT; KarX-EC; KarXT + KarX-EC Arm Matching Placebo Runs in: Australia; Canada; Japan; United Kingdom; United States · 22 sites |
PHASE3 other |
RECRUITING | 325 | Bristol-Myers Squibb INDUSTRY |
2026-06-30 |
|
Effects of Hydroxytyrosol-Rich Olive Polyphenol Dietary Supplement Combined With Mediterranean Diet Adherence on the Cognitive Health of Patients With Mild Cognitive Impairment NCT07672938 Low-Dose Hydroxytyrosol-Rich Olive Juice Polyphenol Supplement; Hig... Runs in: Greece · 1 site |
NA other |
RECRUITING | 141 | Panhellenic Federation of Alzheimer's Disease and Related Disorders OTHER |
2026-06-30 |
|
Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression NCT07676851 No Intervention: Observational Cohort Runs in: China · 1 site |
NA other |
RECRUITING | 44 | Second Affiliated Hospital of Nanchang University OTHER |
2026-06-30 |
|
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation NCT05318976 XPro1595; Placebo Runs in: Australia; Canada; Czechia; France; Germany; Poland; Spai... · 41 sites |
PHASE2 other |
COMPLETED | 207 | Inmune Bio, Inc. INDUSTRY |
2026-06-29 |
|
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders NCT06059313 Submission of the NEO-PI-3 questionnaire; Submission of the Interpe... Runs in: France · 1 site |
NA other |
RECRUITING | 120 | Nantes University Hospital OTHER |
2026-06-29 |
|
WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME NCT07387614 Hospital GamePlan4Care; Health Education Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 55 | Baylor College of Medicine OTHER |
2026-06-29 |
|
Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study NCT07672977 Closed-Loop Auditory Stimulation Runs in: Spain · 1 site |
NA other |
ENROLLING_BY_INVITATION | 30 | Bitbrain INDUSTRY |
2026-06-29 |
|
Effects of X Box Kinect 360 in Alzheimer's Disease NCT07673263 3D Kinect based game; Conventional therapy group Runs in: Pakistan · 1 site |
NA other |
NOT_YET_RECRUITING | 38 | Ziauddin University OTHER |
2026-06-29 |
|
Neurologic Stem Cell Treatment Study NCT02795052 Intravenous and Intranasal BMSC Runs in: United Arab Emirates; United States · 3 sites |
NA other |
RECRUITING | 500 | MD Stem Cells INDUSTRY |
2026-06-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial